Top Story

Aerospan improved pediatric asthma outcomes, regardless of prior therapy

March 2, 2015

HOUSTON — Data presented here indicate Aerospan significantly improved asthma outcomes among children aged 4 to 11 years, regardless of previous asthma treatment types.

Researchers conducted a 12-week, multicenter placebo- and active-controlled trial among pediatric patients with mild to moderate asthma. Study participants (n = 513) received either 80 µg Aerospan (flunisolide hydrofluoroalkane [HFA], Meda Pharmaceuticals) or 160 µg flunisolide HFA or 250 µg flunisolide chlorofluorocarbon (CFC) or 500 µg flunisolide CFC twice daily.

FDA News

FDA grants fast track designation to cannabidiol for Dravet syndrome

February 28, 2015
Insys Therapeutics recently announced that the FDA has granted fast track designation to a pharmaceutical cannabidiol for the treatment of Dravet syndrome, a rare form…
Meeting News Coverage

Repeat testing necessary to detect HIV among infants receiving ART via breast-feeding

February 27, 2015
SEATTLE — WHO recommendations for HIV testing 6 weeks after breast-feeding cessation may need to be re-evaluated, as study findings presented at CROI 2015 suggest…
Meeting News Coverage

Xolair effective, well tolerated in children aged younger than 12 years

February 27, 2015
HOUSTON — Xolair was well tolerated and significantly improved asthma control among children aged younger than 12 years, according to data presented at the…

ACIP confirms recommendation for annual influenza vaccination

February 27, 2015
In a unanimous decision, the CDC’s Advisory Committee on Immunization Practices supported the recommendation that all people aged 6 months and older be vaccinated…
More News Headlines »
Guest Editorial

Childhood Epilepsy

Pediatric Annals, February 2015, Volume 44 Issue 2
More »
Pediatric Annals January 2015

Unusual Diagnoses: Part 1: January 2015

Keck School of Medicine of USC and Pediatric Annals

Index of suspicion—a term used daily by clinicians in general practice who must, in a sea of “normal”…
More »
Meeting News Coverage Video
St. Jude/PIDS conference highlights new frontiers, career potential for infectious disease specialists

St. Jude/PIDS conference highlights new frontiers, career potential for infectious disease specialists

February 23, 2015
MEMPHIS, Tenn. — Elaine I. Tuomanen, MD, director of the Children’s Infection Defense Center at St. Jude…
More »